This HTML5 document contains 129 embedded RDF statements represented using HTML+Microdata notation.

The embedded RDF content will be recognized by any processor of HTML5 Microdata.

Namespace Prefixes

PrefixIRI
wdthttp://www.wikidata.org/prop/direct/
wdtnhttp://www.wikidata.org/prop/direct-normalized/
n9http://dx.doi.org/10.1053/
schemahttp://schema.org/
rdfshttp://www.w3.org/2000/01/rdf-schema#
skoshttp://www.w3.org/2004/02/skos/core#
wikibasehttp://wikiba.se/ontology#
phttp://www.wikidata.org/prop/
rdfhttp://www.w3.org/1999/02/22-rdf-syntax-ns#
n12http://rdf.ncbi.nlm.nih.gov/pubchem/reference/
xsdhhttp://www.w3.org/2001/XMLSchema#
wdshttp://www.wikidata.org/entity/statement/
wdhttp://www.wikidata.org/entity/

Statements

Subject Item
wd:Q43001787
rdf:type
wikibase:Item
schema:description
bài báo khoa học artigo científico наукова стаття, опублікована в серпні 2006 tieteellinen artikkeli 2006년 논문 naučni članak artykuł naukowy vědecký článek artikull shkencor vetenskaplig artikel article scientifique 2006年学术文章 আগস্ট ২০০৬-এ প্রকাশিত বৈজ্ঞানিক নিবন্ধ artículu científicu espublizáu en 2006 scienca artikolo مقالة علمية نشرت في أغسطس 2006 videnskabelig artikel artículo científico publicado en 2006 2006年学术文章 artigo científico 2006年学术文章 artikel ilmiah мақолаи илмӣ 2006年学术文章 บทความทางวิทยาศาสตร์ 2006年学术文章 2006 nî lūn-bûn 2006年学术文章 scientific article published in August 2006 სამეცნიერო სტატია 2006年學術文章 vedecký článok vitskapeleg artikkel 2006年學術文章 artikulong pang-agham научна статия wissenschaftlicher Artikel articol științific bilimsel makale teaduslik artikkel 2006年學術文章 artigo científico 2006年學術文章 2006年の論文 tudományos cikk επιστημονικό άρθρο научни чланак vitenskapelig artikkel scientific article published in August 2006 wetenschappelijk artikel article scientific научни чланак article científic 2006年學術文章 scientific article published in August 2006 מאמר מדעי научная статья articolo scientifico
p:P577
wds:Q43001787-9A6000FD-5643-4CA2-BF58-56C162608C08
wdt:P577
2006-08-01T00:00:00Z
p:P407
wds:Q43001787-A0B697D4-376C-4DA8-9849-09B7335F210B
wdt:P407
wd:Q1860
p:P2093
wds:Q43001787-6714DF4D-9A3D-48B5-9B25-CC9680016A17 wds:Q43001787-49914048-57DA-4D1C-8E18-47BD3EB00362 wds:Q43001787-52E34EED-2777-4D8A-BBDD-BDA4EB961B4E wds:Q43001787-2C4EEF3F-234B-4515-90A3-B5D483A1BB40 wds:Q43001787-3D61F076-EF2A-420B-8FD5-CF25B72B9EB9 wds:Q43001787-2AE12234-EFA8-47B5-BC55-B08D903D815C wds:Q43001787-2BBBD23D-4034-4E3C-BA68-C2C4B13CFD41 wds:Q43001787-20BDD927-2F54-4D24-BB1B-C1AD6AEF2AA8 wds:Q43001787-0FF27FDE-5965-4E9E-94E9-AD70EB26F429 wds:Q43001787-F05E5F29-7CD1-4004-A41D-05E7D2CB4CF9 wds:Q43001787-D65BF2A7-7F28-4EE5-B378-33E22B737A3E wds:Q43001787-A896734C-8C75-473D-BE4C-9F171D0A45B8 wds:Q43001787-0B0326C4-DA39-405F-BC54-C07B29741A83 wds:Q43001787-0B1D1B6C-4927-4979-A097-6D0B2A8D6E05 wds:Q43001787-00A7C30E-D9AF-4AAC-889A-B9DDEA1167A7 wds:Q43001787-02B7091D-B3AF-46D7-ACDC-21C285B6FBC6
wdt:P2093
Ramón Planas José M Sánchez-Tapias Ricard Solá Manuel García-Bengoechea Manuel Romero-Gómez Ramón Pérez Miguel Muñoz-Sánchez Rafael Bárcena Javier Garcia-Samaniego Pedro Escartín Moisés Diago Eva Martínez-Bauer Ricardo Moreno-Otero TeraViC-4 Study Group Milagros Testillano Jaime Enríquez
rdfs:label
Peginterferon-alfa2a plus ribavirin for 48 versus 72 weeks in patients with detectable hepatitis C virus RNA at week 4 of treatment. Peginterferon-alfa2a plus ribavirin for 48 versus 72 weeks in patients with detectable hepatitis C virus RNA at week 4 of treatment.
skos:prefLabel
Peginterferon-alfa2a plus ribavirin for 48 versus 72 weeks in patients with detectable hepatitis C virus RNA at week 4 of treatment. Peginterferon-alfa2a plus ribavirin for 48 versus 72 weeks in patients with detectable hepatitis C virus RNA at week 4 of treatment.
schema:name
Peginterferon-alfa2a plus ribavirin for 48 versus 72 weeks in patients with detectable hepatitis C virus RNA at week 4 of treatment. Peginterferon-alfa2a plus ribavirin for 48 versus 72 weeks in patients with detectable hepatitis C virus RNA at week 4 of treatment.
p:P50
wds:Q43001787-94CD77C1-7132-44C3-A560-1B30D1D52B54 wds:Q43001787-AA36B167-4276-4AA3-99BE-94B6ACE19BD4
wdt:P50
wd:Q59179366 wd:Q64424683
p:P1476
wds:Q43001787-DCC84536-FFAA-499F-A164-47E52D1BB884
wdt:P1476
Peginterferon-alfa2a plus ribavirin for 48 versus 72 weeks in patients with detectable hepatitis C virus RNA at week 4 of treatment
p:P304
wds:Q43001787-892F398D-94C3-470A-A193-68FC29DE0EB0
wdt:P304
451-460
p:P31
wds:Q43001787-62BD13E7-55F8-4865-BCD6-C7FA50704B5C
wdt:P31
wd:Q13442814
p:P921
wds:Q43001787-BD3B6483-C0A5-4136-8935-8C92D3AE7153 wds:Q43001787-E5424EA5-22D8-42DE-A4D7-02B26209D8C6 wds:Q43001787-1A265998-B564-46D0-AEF6-7E634B3C0FAD
wdt:P921
wd:Q421862 wd:Q708693 wd:Q154869
p:P698
wds:Q43001787-85C068A3-E8F9-4E51-997A-879A40D97584
wdtn:P698
n12:16890599
wdt:P698
16890599
p:P1433
wds:Q43001787-DAA5D96F-B5A9-478E-B167-C6E18B0D7BF9
wdt:P1433
wd:Q4039279
p:P433
wds:Q43001787-F960AADB-C2E9-45DD-8D04-A96D7FABA3AC
p:P478
wds:Q43001787-10720EFC-3C57-46C0-BB0F-3C3671EAF926
wdt:P433
2
wdt:P478
131
p:P356
wds:Q43001787-948E01A6-AE48-4AE7-9AA4-60D344692B1E
wdtn:P356
n9:J.GASTRO.2006.05.016
wdt:P356
10.1053/J.GASTRO.2006.05.016